James joined SV in 2018 as a Finance Partner to head up all European finance operations. He focuses on providing the London-based team with support for their investments in the six diversified SVLS Funds, the Dementia Discovery Fund, SV7 Impact Medicine Fund, and all aspects of the administration of the London Stock Exchange-listed International Biotechnology Trust plc.
Prior to SV, James qualified as a Chartered Accountant at RSM (Johannesburg) before relocating back to the UK. He has been specializing in finance and operations in the London investment management industry since 2008 across various sectors.
Outside of SV, James is an avid traveller and all-round sports enthusiast while also providing mentorship to fellow CASS MBA students.
B. Comm (Honours) Accounting, RAU; Executive MBA (Distinction), CASS Business School; Chartered Accountant (South Africa); ACMA, CGMA